The proliferation of substandard medicines represents a deeply concerning issue facing the global healthcare landscape. These deceptive products, often mimicking legitimate medications, here pose a significant danger to consumer safety, undermining treatment effectiveness and potentially leading to severe harmful health outcomes. Motivated by subst